Short answer: in controlled trials, oral glutathione produced a small, instrument-measured drop in skin melanin index over 4 to 12 weeks — statistically real in several studies, non-significant in others, and nowhere near the transformations shown in online photo galleries. Intravenous glutathione for skin lightening was judged contraindicated by a 2024 systematic review, and no trial we found followed anyone after they stopped.
If you searched “glutathione before and after,” you were probably looking for transformation photos. We do not publish them, and we do not sell or promote glutathione as a human skin-lightening product — this is a research-use-only dosage reference, not medical advice. What follows is what the peer-reviewed record actually measured: where the signal is real, where it is weak, and where the honest answer is “we don’t know yet.”
What the research shows over time
Most human glutathione studies for skin appearance are small, short (roughly 4 to 12 weeks), and measure skin tone with instruments (a melanin index or colorimeter), not with the kind of side-by-side photos that circulate online. The results are best described as modest and inconsistent rather than transformational.
In an early randomized, double-blind, placebo-controlled trial, 60 healthy adults took 500 mg/day of oral glutathione or placebo for 4 weeks. The melanin index dropped at all six measured body sites in the glutathione group, but the difference reached statistical significance at only two of six sites (the right cheek and sun-exposed forearm), and the authors explicitly cautioned that long-term safety was not established (Arjinpathana & Asawanonda, 2010). A later 12-week trial testing lower doses (250 mg/day of the reduced or oxidized form) found melanin index and UV spots tended to be lower than placebo, with some sites also showing reduced wrinkling and no serious adverse effects reported (Weschawalit et al., 2017).
Combination approaches have been tested too. An 8-week double-blind RCT reported that pairing topical and oral glutathione produced a lower melanin index than either used alone (Wahab et al., 2021). However, a 12-week Indonesian multicenter RCT of an oral glutathione supplement (combined with vitamin C, alpha-lipoic acid, and zinc) found the reductions in skin tone and UV spots were greater than placebo but not statistically significant (Sitohang et al., 2021) — a useful reminder that “trended better” is not the same as “worked.”
A 2024 systematic review pulled these together: five randomized trials of oral glutathione (250 mg once or twice daily, or 500 mg daily) showed a significant reduction in melanin index versus placebo, but the authors rated the overall body of evidence as having a roughly equal split of low- and high-risk-of-bias studies, and concluded that intravenous glutathione is “contraindicated due to lack of efficacy and side effects” (Sarkar et al., 2024).
| Study (type) | Duration | What was measured |
|---|---|---|
| Arjinpathana & Asawanonda, 2010 (RCT, n=60, oral 500 mg/day) | 4 weeks | Melanin index fell at all 6 sites; significant at only 2 |
| Weschawalit et al., 2017 (RCT, n≈60, oral 250 mg/day) | 12 weeks | Melanin index/UV spots trended lower; no serious adverse effects |
| Wahab et al., 2021 (RCT, n=46, topical + oral) | 8 weeks | Combination lower melanin index than monotherapy |
| Sitohang et al., 2021 (RCT, oral combination) | 12 weeks | Trended better but not statistically significant |
Clinical vs. preclinical vs. anecdotal: The skin-tone trials above are genuine human clinical data (that is the strongest tier here). Glutathione’s role as an antioxidant and its interference with melanin synthesis are supported by laboratory/preclinical work — mechanism, not proof of a cosmetic outcome. The transformation photos you find on social media and vendor pages are anecdotal: uncontrolled, unverified, and the weakest form of evidence.
Realistic expectations
The data support a small, gradual, instrument-measured shift in skin melanin index over weeks in some study populations — not a guaranteed, visible “glow-up.” Several trials failed to reach significance, effects varied site-to-site within the same person, and no study we found demonstrates durable results after supplementation stops. Individual variation is large, and baseline skin type, sun exposure, and co-interventions all confound outcomes.
This is exactly why online “before and after” photos are unreliable, especially for a research compound. Lighting, white balance, camera settings, makeup, angle, and post-processing can manufacture a “result” that no colorimeter would confirm. There is no way to verify dose, product purity, timeline, or whether the photo pair is even the same person. Treat such images as marketing, not evidence.
Oral, topical or injected: does the route change the result?
This is where the searches split — “glutathione injections before and after” is asked almost as often as the oral question — and the evidence points in opposite directions for the two routes.
- Oral. This is where the trial evidence sits. Doses of 250 mg to 500 mg per day over 4 to 12 weeks produced small reductions in melanin index versus placebo, and a 2024 systematic review found a significant pooled reduction across five randomized trials — while rating roughly half of the included studies at high risk of bias (Sarkar et al., 2024).
- Topical plus oral. One 8-week double-blind RCT reported that the combination gave a lower melanin index than either route used alone (Wahab et al., 2021). It is a single trial: treat it as a lead, not a conclusion.
- Intravenous. The same 2024 review concluded that IV glutathione is contraindicated for skin lightening, citing lack of efficacy and side effects (Sarkar et al., 2024). Health regulators including the U.S. FDA and the Philippine FDA have separately warned against injectable glutathione marketed for whitening. Faster delivery did not buy better evidence here — it produced worse.
How long it took in the studies
Every human skin-tone trial identified here ran between 4 and 12 weeks, and each measured its outcome at the end rather than reporting a visible change earlier. The 4-week trial found the melanin index lower at all six measured sites but statistically significant at only two (Arjinpathana & Asawanonda, 2010). The 12-week trials reported trends that were significant in one case and not in another (Weschawalit et al., 2017; Sitohang et al., 2021). Nothing in that record supports a change within days — and nothing in it tells you what happens after you stop, because no trial we reviewed followed participants past the end of supplementation.
Safety & legal status
In the short oral trials above, glutathione was generally well tolerated, with mild and temporary side effects and no serious adverse events reported over 4–12 weeks. That is reassuring but limited: the same authors repeatedly note that long-term safety is unestablished. The picture is worse for the intravenous route — the 2024 systematic review judged IV glutathione contraindicated for skin lightening (Sarkar et al., 2024). More broadly, health regulators including the U.S. FDA and the Philippine FDA have publicly warned against injectable glutathione marketed for skin whitening, citing safety concerns and lack of approval for that use.
Glutathione products referenced here are for laboratory and research use only. Nothing on this page is medical advice, and none of it should be read as a claim that any product we reference causes cosmetic skin changes in people. It is not an approved drug for skin lightening. If you are considering any compound for a personal health or cosmetic reason, talk to a licensed clinician.
Dosage reference
For researchers who need reconstitution and measurement figures rather than promises, we maintain a dedicated reference. See the Glutathione dosage chart for vial-based reconstitution figures, and use our peptide dosage calculator to convert a target concentration into a measured volume. These tools are provided for research documentation only and do not imply any endorsed human use.
FAQ
Are there real before/after photos of glutathione results?
We do not publish them, and we recommend distrusting the ones you find elsewhere. Peer-reviewed studies measure skin tone with a melanin index or colorimeter, not photo galleries, precisely because photos are too easy to stage. No credible study we reviewed documents its outcome with consumer “before and after” images.
How long until changes appear in studies?
Trials ran 4 to 12 weeks and measured small, instrument-detected shifts in melanin index. Even then, results were inconsistent — significant at some body sites but not others, and non-significant in at least one 12-week combination trial (Sitohang et al., 2021). There is no reliable evidence of a fast or dramatic visible change.
Is intravenous glutathione a shortcut to faster results?
No. A 2024 systematic review concluded IV glutathione is contraindicated for skin lightening due to lack of efficacy and side effects (Sarkar et al., 2024), and health regulators have warned against injectable skin-whitening products. Faster is not safer here.
What dose was used in the studies?
The oral trials used 250 mg per day (once or twice daily depending on the arm) or 500 mg per day, over 4 to 12 weeks (Arjinpathana & Asawanonda, 2010; Weschawalit et al., 2017; Sarkar et al., 2024). Those are the doses that were studied for skin tone. They are not a recommendation, and glutathione is not an approved product for that use.
Do the changes last after stopping?
Unknown. No trial we reviewed followed participants after supplementation ended, so there is no evidence of durability in either direction.
Research-use-only. This page summarizes published research for informational purposes and is not medical advice.
